查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1654686

全球乳房 X 光摄影机市场 - 2025 至 2033 年

Global Mammography Machine Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 168 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球乳房 X 光摄影机市场规模达到 26 亿美元，预计到 2033 年将达到 41 亿美元，2025-2033 年预测期内的复合年增长率为 5.1%。

乳房 X 光检查机是一种专门的医学影像设备，透过捕捉乳房组织的详细 X 光影像（称为乳房 X 光检查）来早期发现和诊断乳癌。乳房 X 光摄影机的主要目的是检测肿块、肿瘤、钙化等异常情况，或其他可能表明乳癌或其他疾病的迹象，通常是在任何症状出现之前。

对无症状女性进行筛检性乳房 X 光摄影，以发现乳癌的早期迹象；当出现肿块、疼痛或先前筛检发现的异常等迹像或症状时，进行诊断性乳房 X 光摄影；追踪性乳房 X 光摄影用于监测先前发现的病症或手术或放射治疗等治疗后的情况。

由于多种因素，包括乳癌病例的增加、技术进步和政府健康计划，对乳房 X 光摄影机的需求一直在增加。在乳癌筛检、诊断和追踪中乳房X光检查机的日益普及也是推动市场需求的重要因素。例如，2024 年 6 月，FUJIFIM India Healthcare 与 NM Medical Mumbai 合作，推出了首个富士胶片技能实验室，为放射科医生和放射技师提供 FFDM（全视野数位乳房 X 光摄影）技术的高级培训。

市场动态：

驱动因素与约束因素

乳癌发生率上升

乳癌发生率的上升极大地推动了乳房X光检查机市场的成长，预计在预测期内仍将推动市场的发展。根据世界卫生组织 (WHO) 的数据，2022 年，有 230 万名女性被诊断出罹患乳癌。乳癌影响青春期后各年龄层的女性，但其发生率在后期有所上升。此外，根据乳癌组织的数据，到 2024 年，美国约有 310,720 名女性被诊断出患有侵袭性乳癌，其中 16% 是年龄在 50 岁以下的女性。发病率的不断增长使得需要早期筛检以进行诊断和治疗的患者数量不断增加。

乳癌的早期诊断可大幅提高治疗效果和存活率。乳房 X 光摄影是乳癌筛检的黄金标准，尤其是对于 40 岁以上的女性。乳癌的风险随着年龄的增长而增加。根据美国癌症协会统计，约80%的乳癌病例发生在50岁以上的女性身上。

乳癌宣传月和粉红丝带运动等倡议大大提高了公众对早期乳癌发现重要性的认识。这导致乳房X光照射机器的需求不断增加，特别是在印度、中国和巴西等新兴市场，由于生活方式的改变和人口老化，这些地区的乳癌发病率正在上升。

乳房X光检查机价格昂贵

乳房X光检查机的高成本是乳房X光检查机市场成长的重大障碍，尤其是在资源匮乏的地区和发展中国家。乳房X光检查机的成本可能有所不同，但入门级机器的平均价格范围为 55,000 美元至 75,000 美元。现代数位乳房X光摄影和3D乳房X光摄影（断层合成）系统的成本可能相当高。数位乳房 X 光摄影机的价格从每台 15 万美元到 30 万美元不等，具体取决于其功能（例如 AI 整合和高级成像功能）。

乳房X光检查机的高昂维护费用增加了总体经济负担。这些机器需要定期校准、签订服务合约和软体更新，这可能会导致额外的费用。胶片（用于较旧的模拟系统）或一次性成像组件等消耗品以及维护备件都会增加持续成本。需要训练有素的专业人员来操作和维护这些系统也增加了营运成本。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 依产品类型分类的片段
  • 技术片段
  • 按维度截取片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 乳癌发生率上升
    • 限制
      • 乳房X光检查机价格昂贵
    • 机会
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • 新兴创业公司和关键创新者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态

第 5 章：乳房 X 光摄影机市场（依产品类型）

  • 数位乳房摄影机
  • 模拟乳房X光摄影机

第 6 章：乳房 X 光摄影机市场（按技术划分）

  • 萤幕胶卷乳房X光检查
  • 全视野数位化乳房摄影

第 7 章：乳房 X 光摄影机市场（依尺寸）

  • 2D
  • 3D

第 8 章：乳房 X 光摄影机市场（按应用）

  • 乳房X光检查
  • 诊断性乳房X光检查
  • 追踪乳房 X 光摄影

第 9 章：乳房 X 光摄影机市场（按最终用户划分）

  • 医院
  • 诊断中心
  • 专科诊所
  • 其他的

第 10 章：乳房 X 光摄影机市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 12 章：公司简介

  • GE HealthCare
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 关键进展
    • SWOT 分析
  • Siemens Healthineers AG
  • Hologic, Inc.
  • FUJIFILM Holdings Corporation
  • PLANMED OY
  • Koninklijke Philips NV
  • Metaltronica SpA
  • Konica Minolta Healthcare Americas, Inc.
  • Carestream Health
  • CANON MEDICAL SYSTEMS ARGENTINA SA

第 13 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 14 章：附录

简介目录
Product Code: MI9131

The global mammography machine market reached US$ 2.6 billion in 2024 and is expected to reach US$ 4.1 billion by 2033, growing at a CAGR of 5.1% during the forecast period 2025-2033.

A mammography machine is a specialized medical imaging device used for early detection and diagnosis of breast cancer by capturing detailed X-ray images (called mammograms) of the breast tissue. The primary purpose of the mammography machine is to detect abnormalities such as lumps, tumors, calcifications, or other signs that could indicate breast cancer or other medical conditions, often before any symptoms are noticeable.

Screening mammography is performed on asymptomatic women to detect early signs of breast cancer, diagnostic mammography is performed when there are signs or symptoms such as lumps, pain, or abnormal findings from a previous screening, follow-up mammography is used to monitor previously identified conditions or after treatments like surgery or radiation.

The demand for mammography machines has been increasing due to several factors, including the rise in breast cancer cases, advancements in technology and government health initiatives. The rising adoption of mammography machines for breast cancer screening, diagnosis and follow-ups is also a significant factor driving the market demand. For instance, in June 2024, FUJIFIM India Healthcare in collaboration with NM Medical Mumbai, launched its first Fujifilm Skill Lab for providing advanced training in FFDM (full-field digital mammography) technologies for radiologists and radiographers.

Market Dynamics: Drivers & Restraints

Rising prevalence of breast cancer

The rising prevalence of breast cancer is significantly driving the growth of the mammography machine market and is expected to drive the market over the forecast period. According to the World Health Organization (WHO), in 2022, 2.3 million women were diagnosed with breast cancer. Breast cancer affects women of all ages after puberty, although the incidence rises later in life. Additionally, according to the Breast Cancer Organization, in 2024, approximately 310,720 women diagnosed with invasive breast cancer, 16% of which will be in women younger than 50 years of age in the United States. This growing incidence creates a larger pool of patients who require early screening for diagnosis and treatment.

Early diagnosis of breast cancer greatly improves treatment outcomes and survival rates. Mammography is the gold standard for breast cancer screening, especially for women over the age of 40. This increasing focus on early detection drives greater adoption of mammography machines. The risk of breast cancer increases with age. According to the American Cancer Society, about 80% of breast cancer cases are diagnosed in women over the age of 50. As the global population ages, particularly in countries with longer life expectancies, the demand for mammography machines for regular screenings continues to grow.

Initiatives like Breast Cancer Awareness Month and the Pink Ribbon Campaign have significantly increased public awareness of the importance of early breast cancer detection. This has contributed to rising demand for mammography machines, particularly in emerging markets such as India, China, and Brazil, where breast cancer rates are rising due to lifestyle changes and aging populations.

High cost of mammography machines

The high cost of mammography machines is a significant barrier to the growth of the mammography machine market, especially in low-resource settings and developing countries. The cost of a mammography machine can vary however the average price range for an entry-level machine is $55,000 to $75,000. The cost of modern digital mammography and 3D mammography (Tomosynthesis) systems can be quite high. A digital mammography machine can range from USD 150,000 to USD 300,000 per unit, depending on the features (e.g., AI integration and advanced imaging capabilities).

The high maintenance costs of mammography machines add to the total financial burden. These machines require regular calibration, service contracts and software updates, which can lead to additional expenses. Consumables such as film (for older analog systems) or disposable imaging components and spare parts for maintenance contribute to ongoing costs. The need for trained professionals to operate and maintain these systems also increases operational costs.

Segment Analysis

The global mammography machine market is segmented based on product type, technology, dimension, application, end-user and region.

Product Type:

The digital mammography machine segment is expected to dominate the mammography machine market share

Digital mammography machines provide faster breast screening which further helps to promote early diagnosis of breast cancer. The ability to instantly view and store images digitally speeds up the process, improving workflow efficiency and reducing wait times for patients. With digital systems, images are available within minutes, which allows for quick diagnosis and reduced patient anxiety. Digital mammography reduces the need for physical films and manual development processes, making it more cost-effective in the long term.

For instance, in June 2024, Healthway Medical Network (HMN) launched a new digital mammography machine at its multi-specialty center. This new device offers high-resolution imaging for breast cancer screening, enabling the center's doctors to identify potential abnormalities with better accuracy. Moreover, its adoption is aligned with HMN's initiative of offering comprehensive screenings to promote early diagnosis among patients.

Digital mammography provides better image clarity and higher diagnostic accuracy compared to traditional film-based mammography, particularly for women with dense breast tissue. The ability to digitally manipulate images (contrast, zoom, etc.) also aids in detecting early-stage cancers that might be missed in film mammography.

Geographical Analysis

North America is expected to hold a significant position in the mammography machine market share

Breast cancer is the most common cancer among women in North America especially in the United States and Canada, with a significantly higher incidence compared to many other regions. For instance, according to the American Cancer Society, breast cancer is the second most frequent cancer in women in the United States, and it is the top cause of cancer mortality among Hispanic women. In 2024, 310,720 women were diagnosed with invasive breast cancer, with a projected 42,250 deaths. This high prevalence drives the demand for breast cancer screening and diagnostic tools like mammography machines.

Additionally, according to the Canadian Cancer Society, in 2022, an estimated 28,600 Canadian women were diagnosed with breast cancer. With increasing breast cancer cases, awareness about breast cancer and its early detection is also rising, there is a strong demand for mammography screenings in North America, particularly for women aged 40 and above. Mammography remains the gold standard for early breast cancer detection in the region.

North America has been a leader in the adoption of advanced mammography technologies, such as digital mammography and 3D mammography (tomosynthesis). The adoption of Full-Field Digital Mammography (FFDM) and 3D systems has been particularly strong, thanks to their higher diagnostic accuracy and better detection rates compared to traditional film-based systems.

For instance, in January 2025, GRACE Breast Imaging & Medical Spa of Iowa recently became the first healthcare facility in the United States to install the new Mammomat B.brilliant. The Mammomat B.brilliant is Siemens Healthineers' first completely redesigned mammography machine in over a decade. It includes new 3D image acquisition and reconstruction technology, as well as features for full-field digital mammography or two-dimensional breast imaging, breast biopsy, and titanium contrast-enhanced mammography.

Asia-Pacific is growing at the fastest pace in the mammography machine market

Awareness campaigns focused on early detection and screening are significantly raising the demand for mammography machines in the region. As breast cancer awareness rises, more women are seeking regular screening, driving the need for modern mammography equipment. In countries like India and China, breast cancer awareness is gradually increasing due to efforts by non-profit organizations, media, and healthcare professionals. These campaigns are encouraging women to get screened regularly, which directly drives demand for mammography machines.

For instance, Breast Cancer Awareness Month, commemorated every October, has a unique importance worldwide, but notably in India. In a nation where breast cancer is growing more common, this awareness month acts as an important effort to educate, empower, and motivate action. This has led to greater utilization of mammography services in metropolitan and rural regions.

Competitive Landscape

The major global players in the mammography machine market include GE HealthCare, Siemens Healthineers AG, Hologic, Inc., FUJIFILM Holdings Corporation, PLANMED OY, Koninklijke Philips N.V., Metaltronica S.p.A., Konica Minolta Healthcare Americas, Inc., Carestream Health, CANON MEDICAL SYSTEMS ARGENTINA S.A. and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global mammography machine market report delivers a detailed analysis with 78 key tables, more than 70 visually impactful figures, and 168 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Dimension
  • 2.6. Snippet by Application
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Breast Cancer
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Mammography Machines
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Mammography Machine Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Digital Mammography Machine*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Analog Mammography Machine

6. Mammography Machine Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Screen-Film Mammography*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Full Field Digital Mammography

7. Mammography Machine Market, By Dimension

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 7.1.2. Market Attractiveness Index, By Dimension
  • 7.2. 2D*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. 3D

8. Mammography Machine Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Screening Mammography*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Diagnostic Mammography
  • 8.4. Follow-up Mammography

9. Mammography Machine Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diagnostic Centers
  • 9.4. Specialty Clinics
  • 9.5. Others

10. Mammography Machine Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. GE HealthCare*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
    • 12.1.5. SWOT Analysis
  • 12.2. Siemens Healthineers AG
  • 12.3. Hologic, Inc.
  • 12.4. FUJIFILM Holdings Corporation
  • 12.5. PLANMED OY
  • 12.6. Koninklijke Philips N.V.
  • 12.7. Metaltronica S.p.A.
  • 12.8. Konica Minolta Healthcare Americas, Inc.
  • 12.9. Carestream Health
  • 12.10. CANON MEDICAL SYSTEMS ARGENTINA S.A.

LIST NOT EXHAUSTIVE

13. Assumption and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us